The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMMUNORARE5: A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Anaplastic Thyroid Carcinomas Cohort.
 
Hélène Lasolle
Honoraria - Ipsen; Pfizer; Recordati
Travel, Accommodations, Expenses - Recordati
 
Julien Hadoux
Honoraria - AAA HealthCare; Bayer; Eisai; HRA Pharma; Ipsen; ITM Oncologics; Lilly; Pharma Marathi; Roche
Research Funding - Lilly; Novartis; Sanofi
 
Segolene Hescot
Honoraria - AAA Canada; Eisai; Ipsen
 
Arnaud Jannin
Honoraria - Astellas Pharma; Ipsen; Novartis
Travel, Accommodations, Expenses - Novartis
 
Yann Godbert
Honoraria - Bayer; Eisai; Lilly
Travel, Accommodations, Expenses - Eisai
 
Victor Sarradin
No Relationships to Disclose
 
Alexandre Lugat
Speakers' Bureau - EISAI SAS
Travel, Accommodations, Expenses - Advanz Pharma
 
Patricia Niccoli
No Relationships to Disclose
 
Marie-Eve Garcia
No Relationships to Disclose
 
Marie Vinches
Consulting or Advisory Role - Boehringer Ingelheim; Merck Serono
Travel, Accommodations, Expenses - Eisai; Merck Serono; Merck Serono; Pfizer; PharmaMar
 
Mickael Burgy
Travel, Accommodations, Expenses - MSD Oncology
 
Cécile Vicier
Honoraria - BMSi; Ipsen; seagen
Consulting or Advisory Role - BMSi; Daiichi Sankyo/Astra Zeneca; Novartis; Owkin; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Pascale Tomasini
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Daiichi Sankyo Europe GmbH; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo Europe GmbH; Takeda
 
Diego Tosi
Consulting or Advisory Role - Brenus Pharma; Mabqi; Tes Pharma
Research Funding - Bayer; Ipsen
Patents, Royalties, Other Intellectual Property - I have a pending patent on a new drug combination for prostate cancer treatment
Travel, Accommodations, Expenses - Advanced Accelerator Applications; AstraZeneca; Biogen (I); BMS; Ipsen; Medusas (I); Novartis; Pfizer
(OPTIONAL) Uncompensated Relationships - Brenus Pharma; Phost'in
 
Sara Calattini
No Relationships to Disclose
 
Sylvie Bin
No Relationships to Disclose
 
Fabien Subtil
No Relationships to Disclose
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; Eisai; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Pharma&; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); NOVARTIS (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech; SEAGEN
 
Marie Béguinot
Honoraria - Gilead Sciences; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Menarini; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; MSD Oncology; Novartis; Pfizer; Roche